Abstract
The present disclosure relates to cell penetrating anti-DNA binding proteins. Compositions comprising these binding proteins may be may be useful for delivering agents to cells and treating diseases such as cancer.
Original language | English |
---|---|
Patent number | WO/2019/018428 |
Priority date | 17/07/16 |
Filing date | 17/07/18 |
Publication status | Submitted - Jul 2017 |
Keywords
- autoantibody
- antibody
- humanization
- di-scFv